Two Sigma Advisers LP Has $64.25 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Two Sigma Advisers LP increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4,824.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 123,100 shares of the medical equipment provider’s stock after purchasing an additional 120,600 shares during the period. Two Sigma Advisers LP’s holdings in Intuitive Surgical were worth $64,253,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Merit Financial Group LLC boosted its stake in Intuitive Surgical by 49.7% in the 4th quarter. Merit Financial Group LLC now owns 6,664 shares of the medical equipment provider’s stock valued at $3,478,000 after buying an additional 2,213 shares in the last quarter. Sanibel Captiva Trust Company Inc. raised its stake in Intuitive Surgical by 46.9% during the fourth quarter. Sanibel Captiva Trust Company Inc. now owns 930 shares of the medical equipment provider’s stock worth $485,000 after acquiring an additional 297 shares in the last quarter. Ameritas Advisory Services LLC lifted its holdings in shares of Intuitive Surgical by 24.8% during the fourth quarter. Ameritas Advisory Services LLC now owns 1,628 shares of the medical equipment provider’s stock valued at $850,000 after acquiring an additional 324 shares during the period. LVW Advisors LLC boosted its stake in shares of Intuitive Surgical by 1.3% in the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after purchasing an additional 19 shares in the last quarter. Finally, Diversify Wealth Management LLC grew its holdings in shares of Intuitive Surgical by 101.7% in the 4th quarter. Diversify Wealth Management LLC now owns 8,063 shares of the medical equipment provider’s stock worth $4,414,000 after purchasing an additional 4,066 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

ISRG has been the subject of several analyst reports. Royal Bank of Canada cut their price target on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. JPMorgan Chase & Co. lifted their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Erste Group Bank downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 17th. Barclays decreased their price target on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a research report on Thursday, April 24th. Finally, CICC Research initiated coverage on Intuitive Surgical in a research report on Monday, January 27th. They issued a “neutral” rating and a $550.00 price objective for the company. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $598.95.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $561.63 on Tuesday. Intuitive Surgical, Inc. has a 52 week low of $395.60 and a 52 week high of $616.00. The stock’s 50 day moving average price is $506.50 and its two-hundred day moving average price is $537.23. The stock has a market capitalization of $201.30 billion, a price-to-earnings ratio of 87.62, a PEG ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.19 billion. During the same quarter last year, the company earned $1.50 EPS. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 188 shares of the business’s stock in a transaction on Friday, February 28th. The stock was sold at an average price of $566.94, for a total value of $106,584.72. Following the completion of the sale, the chief financial officer now directly owns 7,162 shares in the company, valued at $4,060,424.28. The trade was a 2.56% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Myriam Curet sold 2,401 shares of the business’s stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the completion of the sale, the executive vice president now directly owns 353 shares of the company’s stock, valued at approximately $205,093. The trade was a 87.18% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 32,700 shares of company stock valued at $16,865,621. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.